PrEP Research 34% of transmasculine people given PrEP info by providers September 25, 2019 Although oftentimes overlooked in HIV and PrEP public health efforts, transmasculine...
Research Treatment What do people think of long-acting HIV meds? August 15, 2019 Over the years, HIV has evolved into a chronic condition necessitating life-long medication...
Our impact Research Coordinated response to antibiotic-resistant gonorrhea August 14, 2019 The number of cases of gonorrhea happening every year is going up, and public concern over...
Research Islatravir: A potential PrEP & HIV drug now being tested August 13, 2019 There’s a new antiretroviral, from a new class of medication, currently being tested for...
Community Research New data on HIV incidence among trans women in San Francisco July 24, 2019 At IAS 2019, Erin Wilson, DrPH, MPH presented new data on HIV incidence among trans women in...
PrEP Research IAS 2019 – PrEP use by transmasculine & transfeminine folks: New data from Northern California July 24, 2019
Research Substance use ARTEMIS improves mood, reduces viral load for men using meth July 23, 2019 New research shared at IAS 2019 showed a surprising effect of a counseling intervention to...
Research Substance use IAS 2019 – Mindfulness intervention reduces viral load for men using meth July 23, 2019
PrEP Research No effect of cocaine and PrEP on kidneys, but adherence suffers June 21, 2019 Men who have sex with men and trans women report higher levels of cocaine, meth and other...
PrEP Prevention Research New research: Is Descovy a new option for PrEP? March 6, 2019 Long-awaited results from a three-year PrEP clinical trial evaluating a new candidate...
PrEP Prevention Research Low PrEP awareness and use among cis women seeking STI services February 19, 2019 In the US nearly 20% of new HIV infections are among cisgender women (cis women) with higher...
Living well Research Treatment HIV inflammation linked to complex motor skill impairment February 5, 2019 Even in its mildest form, HIV-associated neurocognitive impairment can cause problems related...
PrEP Research For people having anal sex, PrEP 2-1-1 is effective at preventing HIV December 19, 2018 Daily use of PrEP reduces the risk of HIV infection by up to 99% Yet there are a few factors...
Prevention Research Testing Is the “ostrich effect” blocking 1 in 6 people from HIV testing? October 25, 2018 Testing for HIV is fast, confidential and freely available in many areas across the US Yet an...
PrEP Prevention Research Sixth case of rare PrEP failure reported—here’s what to know. October 5, 2018 In San Francisco, the sixth case of PrEP failure in a patient with high adherence was...
Research Disappointing results from “kick and kill” HIV cure study, explained August 14, 2018 At AIDS 2018, the 22nd International AIDS Conference held in July, researchers shared results...
PrEP Prevention Research Hormone levels not affected by PrEP in trans women August 13, 2018 Using PrEP for HIV prevention does not lower levels of feminizing hormones, and hormones only...
Living well Research Treatment U=U Almost, but not quite, HIV undetectable. Is that a problem? July 25, 2018 If your viral load isn’t undetectable—but is close—is there any impact on your...
Research Broadly neutralizing antibody PGT121 reduces hidden viral reservoir July 11, 2018 A broadly neutralizing antibody known as PGT121, when used with an immune stimulant, may be...
Research One man’s experience with gene therapy May 23, 2018 In 2015, Andrew Caldwell heard about an HIV cure study that would involve his stem cells...
Prevention Research An HIV study: Starting for the money, staying for the questions May 21, 2018 About a year and a half ago I got an alert while looking at Grindr that Bridge HIV was...
Research New findings on inflammation & how it affects people with HIV April 23, 2018 Previous research has shown the association between increased inflammation in people living...
PrEP Prevention Research PrEP use since 2012 is up, but uptake falls short of need April 4, 2018 The number of people using tenofovir/emtricitabine (Truvada) for PrEP exceeded 77,000 in...
